Precision genome editing accelerates the discovery of the genetic determinants of phenotype and the 22 engineering of novel behaviors in organisms. Advances in DNA synthesis and recombineering have 23 enabled high-throughput engineering of genetic circuits and biosynthetic pathways via directed 24 mutagenesis of bacterial chromosomes. However, the highest recombination efficiencies have to date 25 been reported in persistent mutator strains, which suffer from reduced genomic fidelity. The absence of 26 inducible transcriptional regulators in these strains also prevents concurrent control of genome 27 engineering tools and engineered functions. Here, we introduce a new recombineering platform strain,
140 glucose, 0.2% casamino acids, thymine (100 µg/mL), and trimethoprim (50 µg/mL) was used. M9 141 minimal media with valine (20 µg/mL) was used to select for the ilvG + genotype. All M9 minimal media 142 was supplemented with biotin at 10 µg/mL to account for the biotin auxotrophy common to all EcNR1-143 derivative strains. and a web link to sequence-level detail of each modification. Supplementary Table S3 provides a 156 summary of strain identification numbers and genotypes for the BioDesignER lineage.
157
Growth rate measurements 158 Two clones of each strain were cultured overnight in LB Lennox (LB) medium with chloramphenicol.
159
The following morning each strain culture was back-diluted 1:100 into two media types: (1) LB with aTc 160 (LB+aTc) (2) LB. The resulting inocula were divided into four technical replicates and then grown for up 161 to 18 hours in a Biotek Synergy 2 microplate reader. The growth rate at early exponential phase was 162 calculated from the resulting optical density data using custom analysis scripts in python.
163

Competent cell preparation and recombineering
Strains were grown overnight in LB Lennox medium (LB) with antibiotics as appropriate at 37°C. The 165 following morning each strain culture was back-diluted 1:100 into 25 mL LB+aTc and grown at 37°C 166 until they reached OD600 0.3-0.4. The resulting mid-log cultures were chilled in a 4°C ice-water bath.
167
Cultures were centrifuged (Beckman-Coulter Allegra 25R) at 8000 xg and subjected to two washes: (1) 168 25 mL chilled water (2) 15 mL chilled 10% glycerol. The cell pellets after the final glycerol wash were 169 resuspended in 10% glycerol, yielding approximately 500 uL of competent cells given the residual cell 170 mass from the wash.
171
Due to their different induction and growth requirements, EcNR2 and EcNR2.nuc5-strains were grown 172 overnight at 30°C, back-diluted 1:100 into 25 mL LB+chlor media, and cultured at 30°C until they 173 reached OD600 0.3-0.6. The λ-Red machinery was induced by incubating the cultures in a 42°C water 174 bath for 15 minutes after which the strains were chilled in a 4°C ice-water bath for at least 10 minutes.
175
The remainder of the preparation for EcNR2 and EcNR2.nuc5-follows the same aforementioned wash 176 steps.
177 40 uL of competent cells were used for each recombineering reaction. Oligos were diluted to 50 µM 178 concentration in 10% glycerol and 10 µL of the diluted oligo was added to the competent cell mixture.
179
For water control reactions, 10 µL of water was added. For multiplexed reactions, 10 µL of a cocktail 180 with a total oligo concentration of 50 µM was used. The resulting cell-oligo mix was transferred to a 181 chilled cuvette (1 mm gap, VWR) and electroporated using a BTX TM -Harvard Apparatus ECM TM 630 182 Exponential Decay Wave Electroporator with the following parameters: voltage (1800 V), resistor (250 183 Ω), capacitor (25 μF).
184
Fluorescence-coupled scar-free selection/counter-selection
185
Working from the ΔthyA strain RE095 and derivative strains ( Supplementary Table S2 ), a dsDNA thyA 186 cassette with or without a fluorescence gene (Supplementary Figure S1 ) was amplified with 35-50 bp 187 homology to a target genomic locus and integrated via standard recombineering as described above,
188
with the exception that cells were made competent by growing in LB supplemented with thymine (100 189 µg/mL) and trimethoprim (50 µg/mL). Integrants of thyA were selected for on LB media. Colonies with 190 fluorescence-coupled thyA cassettes were screened visually for fluorescent phenotypes on a blue-light 191 transilluminator. Proper insertion of the cassette was confirmed by locus-specific colony PCR.
192
Replacement of the thyA cassette was performed through recombineering with a ssDNA or dsDNA 193 cassette as described in Supplementary Table S2 
214
(https://benchling.com/organizations/arkinlab). Individual colonies were inoculated in LB with an Kinetic growth and fluorescence measurements were taken every 5 or 10 minutes for 12 hours.
218
Absorbance was measured at 600 nm. GFP fluorescence was measured using 485/20 nm and 520/15 219 nm filter cubes for excitation and emission, respectively. mKate fluorescence was measured using 220 560/20 nm and 615/30 nm filter cubes for excitation and emission, respectively. Fluorescence values 221 measured nearest OD 0.5 were used to estimate absorbance-normalized fluorescence in each channel. 
258
Iterative recombineering cycling 259 Strains were prepared for transformation using the competent cell protocol described above using 25 260 mL of culture with a target OD600 of 0.3. Each culture was resuspended in ~500 µL of 10% glycerol 261 after washes. Each transformation consisted of 40 uL competent cells mixed with 10 µL of 50 µM oligo 262 mix. After transformation, cells were recovered in 3 mL LB supplemented with carbenicillin. The 263 recovery culture was grown to saturation before beginning the next round of competent cell prep and 264 recombination. In parallel, the recovery culture was diluted 1:60 into an additional 3 mL of LB
265
supplemented with carbenicillin and grown to saturation prior to measurements using flow cytometry 266 (Sony SH800).
268
RESULTS
269
Rational strain design
270
We introduced multiple targeted modifications to an MG1655-derivative strain to decrease 271 recombination cycle time, reduce toxicity of the recombination machinery, and introduce a transient 272 hypermutation phenotype via hypermethylation ( Figure 1A -B, Table 1 ). Using EcNR1 (18) as the host,
273
we refactored the λ-Red recombination machinery, which consists of the genes exo, bet, and gam, and 
285
To remove a valine-sensitive growth defect present in E. coli K-12, we restored expression of ilvG. K-286 12 contains three acetohydroxy acid synthases (ilvB, ilvG, ilvH) that are involved in branch-chained 287 amino acid biosynthesis. K-12 does not express ilvG due to a natural frameshift mutation and thus 288 exhibits a growth defect in the presence of exogenous valine and the absence of isoleucine (35, 36) .
289
This valine-sensitive growth phenotype is alleviated by restoration of ilvG (37). Using oligo-mediated 290 recombination (Methods) we removed the frameshift mutation in the endogenous ilvG gene, which has 291 been reported to enable faster growth in minimal media. We called this strain pTet-λ.
292
We next incorporated genomic modifications shown to improve recombination efficiency. Using a scar-293 free genome engineering workflow that utilizes a novel thyA selection/counter-selection cassette 294 containing a fluorescent marker (Supplementary Figure S1 , Methods), we iteratively generated multiple beneficial mutations. 
319
To assess the effect of BioDesignER modifications on strain fitness, we measured the growth rates of 320 key strains in the modification lineage in LB rich media (Figure 2A ). We noted that, in general, doubling 321 times decreased as additional modifications were made. Additionally, in contrast to cell death reported 322 for extended co-expression of λ-kil with the recombination machinery (34) transformed an oligo to inactivate sfGFP via incorporation of a premature stop codon. We also 330 performed a control reaction in each case using water in place of oligo. After recovery and outgrowth 331 we measured the fluorescence profiles of each strain using flow cytometry ( Figure 2B ). We observed increases in recombination efficiency at each modification stage with single cycle conversion rates 333 improving from 1.6±0.1% (mean ± 1 standard deviation) in pTet-λ to 25.4±1.0% in BioDesignER.
334
To investigate the efficacy of mismatch repair evasion on recombination efficiency, we compared
335
BioDesignER against pTet-λ derivative strains containing mismatch repair modifications and against 336 two standard ΔmutS recombineering variants, EcNR2 and EcNR2.nuc5-. BioDesignER (25.4±1.0%) 337 exhibits much higher recombination efficiency than pTet-λ with dam over-expression (damOE, 338 6.91±0.19%) or ΔmutS (12.9±1.7%) as hypermutagenesis strategies ( Figure 2C, left 
342
( Figure 2C, right panel) . We were surprised to find that the recombineering efficiency of BioDesignER 343 decreased by nearly two-fold when grown at a lower temperature.
344
dsDNA recombination enhancements: Knocking out endogenous exonucleases has been reported to 345 significantly reduce or abolish dsDNA recombination efficiency (39). We measured the efficiency of 346 dsDNA recombination in pTet-λ and BioDesignER and found no significant reduction in recombination 347 efficiency ( Figure 2D ). This suggests that λ-exo is sufficient to process dsDNA recombination templates 348 in the absence of multiple host exonucleases. A previous study reported that dsDNA recombination is 349 at least an order of magnitude less efficient in a four-nuclease deficient genotype (ΔexoX, ΔrecJ, ΔxseA,
350
ΔxonA) with abolished dsDNA recombination activity in a three-nuclease (ΔrecJ, ΔxseA, ΔxonA) 351 knockout (39). We note here that we were successful in generating dsDNA recombinants in
352
EcNR2.nuc5-at a similar efficiency to EcNR2 with no alteration to the recombineering protocol,
353
suggesting that another nuclease is aiding dsDNA recombination in E. coli or that recombination can 354 occur through an exonuclease-independent mechanism. 
355
369
To characterize the induction profiles of each regulator, we quantified the fluorescence levels and 370 growth rates of cells transformed with multi-copy plasmids. We constructed a set of GFP expression 371 plasmids with promoters responsive to each regulator ( Figure 2E respectively. In both copy-number contexts, GFP expression with no inducer was indistinguishable from 380 a control plasmid lacking gfp. We found that repressor levels were insufficient to fully repress GFP 381 expression on plasmids with the ColE1 replication origin. We note that AraC-regulated GFP expression 382 saturates near 33 µM (5 µg/mL, 0.0005%) arabinose, a much lower saturation point than common 383 plasmid-based systems (0.1% arabinose).
384
Single-cell distributions observed through flow cytometry revealed unimodal distributions of GFP 385 expression for nearly all induction conditions ( Figure 2E ). GFP expression from both cumate-and IPTG-386 responsive promoters produced monotonic, decreasing coefficient of variation noise profiles for 387 increasing inducer levels (Supplementary Figure S3) Figure S3) , manifest in Figure 2E as the broad, weakly bimodal fluorescence Figure 3A, Supplementary Figure S4) . Specifically, the integration Safe Sites are intergenic regions located between two convergently transcribed, non-essential genes that do not 400 exhibit any phenotypes or growth defects across the majority of biochemical conditions screened in 401 previous high-throughput studies (14, 43) ( Supplementary Table S5 ), and contain no annotated features 402 (small RNAs, promoters, transcription factor binding sites) according to RegulonDB (44) 
403
( Supplementary Table S6 ).
404
To characterize gene expression variation across the chromosome, we measured the expression of Figure 3B ). This result was consistent with expected variations in local chromosomal copy number due 410 to bi-directional replication dynamics during growth (45, 46) . Interestingly, we observed a much stronger 411 correlation of expression to distance from replication origin for chromosome Arm 1, though mKate2 412 expression at Safe Site 8 was a low outlier. We also assessed the effect of integration at each Safe Site 413 on cellular fitness by measuring growth rates for each integration strain. We observed that, in general, 
421
Site strains. For each strain we independently transformed (1) an oligo to inactivate sfGFP, (2) an oligo 422 to inactivate mKate2, or (3) an oligo cocktail to inactivate both reporters. We also performed a control 423 reaction in each case using water in place of oligo. For Safe Sites that lie on opposite sides of the 424 replication fork, we designed appropriate oligos to ensure recombination targeting the lagging strand.
425
We found that recombination rates were consistently high across the chromosome with Safe Sites 426 displaying single cycle, single site conversion rates of 17.0±6.70% and 19.7±5.7% for sfGFP and 427 mKate2, respectively ( Figure 3C ). We also report single cycle, multiplex conversion rates of 7.5±4.4%
428
for the sfGFP, 7.9±2.9% for the mKate2, and 6.3±2.3% for both reporters when transformed with the 429 dual oligo cocktail. 467 nucleotides/genome/replication, 4.55×10 -9 (CI: 3.10-6.19×10 -9 ), and 6.54×10 -9 (CI: 4.77-8.51×10 -9 ) for 468 pTet-λ, damOE, and BioDesignER, respectively. By comparison, we observed mutation rates of 2.98×10 -8 (CI: 2.13-3.93×10 -8 ) for the control pTet-λ ∆mutS, which was similar to the rate of 2.73×10 -8 470 (CI: 1.79-3.81×10 -8 ) observed for EcNR2. For all strains assayed, all chloramphenicol-resistant colonies 471 were also fluorescent. From a set of 54 individually sequenced chloramphenicol-resistant clones, we 472 observed 8 unique genotypes arising from spontaneous mutations (Supplementary Figure S6 ).
473
To investigate the effect of λ-Red induction on global mutation rates and compare the mutagenic effect 474 of dam over-expression to deletion of mutS, we tested the mutation rates for pTet-λ, damOE, and pTet-475 λ ∆mutS both with and without aTc induction (Supplementary Figure S6) . We found no effect on global 476 mutation rates due to aTc induction (i.e. expression of the λ-Red machinery) in pTet-λ and pTet-λ 477 ∆mutS. Consistent with prior work (31), we observed an increase in mutation rate for damOE under aTc 478 induction -specifically, 2.4-fold in this work. Finally, we noted that even with aTc induction damOE was 479 still less mutagenic than pTet-λ ∆mutS, suggesting that BioDesignER uniquely strikes a balance 480 between on-target and off-target mutagenesis rates.
481
To quantify this balance, we compared the recombination and mutagenesis rates for a selection of 482 control strains and BioDesignER ( Figure 4B) . The resulting trade-off space can be divided into two 483 regimes where strains falling in the shaded region exhibit a favorable trade-off between recombination 484 rate and mutation rate. BioDesignER falls in the favorable subspace, while MMR-deficient strains such 485 as EcNR2 and the pTet-λ ∆mutS fall in the unfavorable regime above the tradeoff line. To summarize 486 this result we introduce the metric recombineering fidelity, which we define as the product of fold-487 increase in recombination rate and fold-decrease in mutagenesis rate, each relative to EcNR2. Using 488 this metric we calculate that BioDesignER exhibits 7.3-fold greater recombineering fidelity than EcNR2
489
(1.75-fold improvement in recombination rate and 4.17-fold decrease in mutagenesis rate) ( 
499
BioDesigner to pTet-λ ( Figure 5A) , EcNR2, and EcNR2.nuc5-(Supplementary Figure S7) 
503
( Figure 5B ).
504
Given the higher single-cycle conversion rate of EcNR2.nuc5-compared to BioDesignER (Figure 2C,   505 right panel), we were surprised by the comparable performance of the two strains over multiple 506 recombineering cycles. We partly attribute this parity to uncharacteristically low and sporadic single-507 cycle efficiencies that we repeatedly observed for EcNR2.nuc5-replicates (Supplementary Figure S7 ).
508
Regardless, while both BioDesignER and EcNR2.nuc5-exhibited similar multiplex editing efficiencies,
509
EcNR2.nuc5-requires culturing at 30-32°C and is a persistent mutator, which increases recombineering 510 cycle time and basal mutation rate, respectively -thus limiting its overall utility as a reliable strain for 511 multiplex genome editing.
513
DISCUSSION
514
High-efficiency genome engineering in bacteria enables breadth (24) and depth (17) 
538
We have increased recombineering fidelity in BioDesignER by striking a balance between 539 recombination efficiency and mutagenesis rates. A high recombineering fidelity platform such as this 540 may provide new avenues to multiplex genome remodeling using CRISPR-Cas9 techniques. CRISPR-
541
Cas9 genome editing approaches in bacteria are limited by recombination efficiency to rescue double-542 strand breaks. Linking CRISPR-Cas9 counterselection of native sequences with high-efficiency, multi-543 site recombineering may allow concurrent selection of many modifications from a large bacterial 544 population with little off-target activity, thereby enabling researchers to explore unprecedented genetic 545 diversity.
547
While BioDesignER exhibits robust functionalities with respect to recombineering fidelity, comparing the 548 recombination efficiency of the BioDesignER lineage to EcNR2-derived strains reveals inconsistent 549 results related to culture temperatures. Specifically, we found a nearly two-fold reduction in 550 recombination efficiency for BioDesignER at 30°C compared to 37°C, resulting in recombineering 551 efficiencies similar to EcNR2 ( Figure 2C ). This reduction suggests some uncharacterized temperature-552 specific reduction in recombination efficiency and could reflect reduced ssDNA access to the replication 553 fork, lower ssDNA half-life at reduced temperatures, or perhaps uncharacterized temperature-554 dependent expression of the λ-Red machinery from pTet.
556
While constructing BioDesignER, we developed multiple selection/counter-selection strategies that may 557 be of general use for bacterial genome engineering. These strategies combine selection/counter-558 selection and fluorescence screening components to accelerate scar-free genome engineering.
559
Specifically, the genetic cassettes utilize selection/counter-selection of thyA, building on work from 560 FRUIT (48). This approach requires two recombineering transformations: a dsDNA integration of the 561 fluorescence-coupled thyA cassette at the target genomic locus followed by removal of the cassette 562 using ssDNA or dsDNA. The genetic modification of interest can be incorporated at either integration 563 stage. In comparison, CRISPR-based genome editing workflows, which are gaining popularity, require multiple steps including guide plasmid construction, co-transformation with Cas9, and subsequent 565 curing. Thus, the selection/counter selection methodologies developed here allow a simple and 566 effective approach to genome engineering.
568
Development of BioDesignER points to genome design strategies for next-generation biotechnology 569 hosts. As synthetic biology matures, the application space is expanding beyond prototypical genetic 570 circuits and metabolic pathways in laboratory environments to robust engineered functions in ecologies 571 with high biotic and abiotic complexity, including soil, wastewater, and the human gut (49). Efficient and 572 sustained activity of engineered functions in these environments will require programmed behaviors to 573 be optimized in phylogenetically diverse microbes. We anticipate the integrative approach used to 574 develop and characterize BioDesignER can be used as a template to develop high-efficiency 575 recombineering platforms for new bacterial hosts.
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